Quality of Evidence:
Coadministration has not been studied but may increase lopinavir/ritonavir and telithromycin concentrations as telithromycin is both an inhibitor and substrate of CYP3A4. In addition, caution should be exercised as both drugs have possible risks of QT prolongation and/or TdP on the CredibleMeds.org website. If coadministration is necessary, clinical monitoring including ECG assessment is recommended.
View all available interactions with
Lopinavir/ritonavir (LPV/r) by clicking